YILI(SH:600887) Chengtong Securities·2025-05-23 02:20Investment Rating - The report maintains a "Strong Buy" rating for the company [5][9]. Core Views - The company is expected to recover from a challenging 2024, with a projected revenue of 119 billion yuan for 2025, indicating a cautious but optimistic outlook for demand [2][9]. - The company has effectively reduced inventory levels, leading to a potential recovery in quarterly revenue [1][2]. - The brand maintains a strong market position, with the highest market share in various product categories, including liquid milk and infant formula [3][4]. Financial Performance Summary - For 2024, the company reported a revenue of 115.78 billion yuan, a decrease of 8.24% year-on-year, and a net profit of 8.45 billion yuan, down 18.94% [1]. - The gross margin improved to 33.88%, an increase of 1.30 percentage points year-on-year, while the net profit margin was 7.33%, a slight decrease of 0.84 percentage points [1]. - In Q1 2025, the company achieved a revenue of 33.02 billion yuan, a year-on-year increase of 1.35%, with a net profit of 4.87 billion yuan, down 17.71% [2]. Market Position and Strategy - The company has a diversified product portfolio, including liquid milk, dairy beverages, and infant formula, which has shown resilience in a challenging economic environment [3]. - The company is focusing on inventory reduction and optimizing product freshness to enhance sales performance [2][3]. - The company plans to continue its high cash dividend policy, proposing a total cash dividend of 7.73 billion yuan for 2024, which represents 91.40% of its net profit [4]. Future Outlook - The company anticipates a gradual improvement in the supply-demand balance for raw milk in 2025, particularly in the third quarter due to seasonal demand [2]. - Revenue projections for 2024, 2025, and 2026 are 118.7 billion yuan, 124 billion yuan, and 130.2 billion yuan, respectively, with expected net profits of 10.7 billion yuan, 11.3 billion yuan, and 11.7 billion yuan [9][10].